BLFS Q3 2024 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena

BLFSBioLife Solutions, Inc.

$921M

Q3 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$31M+29.7% YoY

Gross Profit

$22M71.3% margin

Operating Income

-$2M-5.1% margin

Net Income

-$2M-5.6% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

+55.1%

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

$4M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$382M

Total Liabilities

$56M

Stockholders' Equity

$325M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$24M	+29.7%
Gross Profit	$22M	$12M	+81.8%
Operating Income	-$2M	-$9M	+82.2%
Net Income	-$2M	-$29M	+94.2%

Revenue Segments

Product

$23M42%

Product, Cell Processing

$19M34%

Rental Revenue

$5M9%

Service

$5M8%

Product, Freezer and Thaw

$4M7%